Par Drugs and Chemicals Limited (PAR) — corporate announcements

All
Important
Financial Update
Fund Raise
Board Meeting
Dividend/Bonus
JV/Acquisition
Investor Meet
Insider Trade
Pledging
Others

Download our app

Get the best experience on mobile

Join 5K+ users on Alpha Tribe

Par Drugs and Chemicals Limited

$PAR

Incorporated in 1982, Par Drugs & Chemicals Ltd manufactures APIs and Fine Chemicals

Pharmaceuticals

05-09-2026 | 10:19 am

Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication

PDF

01-09-2026 | 05:43 pm

Par Drugs And Chemicals Limited announced its 27th Annual General Meeting will be held in Vadodara. The Annual Report is available via web-link and distributed electronically to shareholders with registered emails.

PDF

22-08-2026 | 06:16 pm

Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 26, 2026

PDF

22-08-2026 | 06:06 pm

Par Drugs' board met. Approved FY26 annual results: Revenue ₹103.66 Cr, PAT ₹13.11 Cr. Key approvals include higher remuneration for MD, CEO (₹0.64 Cr each), & Ind. Director (₹0.24 Cr), all subject to shareholder vote. MD/CEO now authorized for investment management.

PDF

22-08-2026 | 06:04 pm

Par Drugs And Chemicals Limited has informed the Exchange regarding Appointment of M/s Maulin Shah & Associates, Cost Accountant as Cost Auditor of the Company w.e.f. April 01, 2026.

PDF

Download our app

Par Drugs and Chemicals Limited

Par Drugs and Chemicals Limited

Copy of Newspaper Publication

Par Drugs and Chemicals Limited

Updates

Par Drugs and Chemicals Limited

Shareholders meeting

Par Drugs and Chemicals Limited

Outcome of Board Meeting

Par Drugs and Chemicals Limited

Appointment